Peter N. Brawn

1.1k total citations
27 papers, 900 citations indexed

About

Peter N. Brawn is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Peter N. Brawn has authored 27 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 10 papers in Rheumatology and 9 papers in Surgery. Recurrent topics in Peter N. Brawn's work include Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and Urologic and reproductive health conditions (10 papers). Peter N. Brawn is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and Urologic and reproductive health conditions (10 papers). Peter N. Brawn collaborates with scholars based in United States, United Kingdom and Portugal. Peter N. Brawn's co-authors include V. O. Speights, David H. Hussey, Andrew C. von Eschenbach, Douglas E. Johnson, Alberto G. Ayala, Mark W. Riggs, Charles F. Johnson, K. Scott Coffield, Vera M. Kolb and Walter B. Dandliker and has published in prestigious journals such as Cancer, The Journal of Urology and Journal of Clinical Pathology.

In The Last Decade

Peter N. Brawn

27 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter N. Brawn United States 16 595 242 240 169 134 27 900
D B Siders United States 16 733 1.2× 196 0.8× 297 1.2× 186 1.1× 168 1.3× 26 980
W A Sakr United States 7 605 1.0× 136 0.6× 123 0.5× 102 0.6× 144 1.1× 10 738
Sven Wenske United States 21 684 1.1× 283 1.2× 185 0.8× 172 1.0× 188 1.4× 41 1.2k
S. Melchior Germany 11 380 0.6× 139 0.6× 67 0.3× 149 0.9× 336 2.5× 34 672
H Knönagel Switzerland 13 391 0.7× 274 1.1× 45 0.2× 119 0.7× 193 1.4× 33 791
Lawrence R. Ragard United States 13 360 0.6× 194 0.8× 54 0.2× 253 1.5× 168 1.3× 28 1.1k
Paula Kujala Finland 19 589 1.0× 168 0.7× 99 0.4× 285 1.7× 282 2.1× 69 994
Tateki Yoshino Japan 14 458 0.8× 257 1.1× 64 0.3× 185 1.1× 208 1.6× 35 863
Takashi Fukagai Japan 14 477 0.8× 138 0.6× 77 0.3× 187 1.1× 81 0.6× 67 727
S. Pomer Germany 13 353 0.6× 159 0.7× 44 0.2× 147 0.9× 326 2.4× 51 722

Countries citing papers authored by Peter N. Brawn

Since Specialization
Citations

This map shows the geographic impact of Peter N. Brawn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. Brawn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. Brawn more than expected).

Fields of papers citing papers by Peter N. Brawn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N. Brawn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. Brawn. The network helps show where Peter N. Brawn may publish in the future.

Co-authorship network of co-authors of Peter N. Brawn

This figure shows the co-authorship network connecting the top 25 collaborators of Peter N. Brawn. A scholar is included among the top collaborators of Peter N. Brawn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter N. Brawn. Peter N. Brawn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brawn, Peter N., Dennis W. Jay, Donald M. Foster, et al.. (1996). Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates. The Prostate. 28(5). 295–299. 4 indexed citations
2.
Speights, V. O. & Peter N. Brawn. (1996). Serum prostate specific antigen levels in non‐specific granulomatous prostatitis. British Journal of Urology. 77(3). 408–410. 28 indexed citations
3.
Speights, V. O., et al.. (1995). Evaluation of age-specific normal ranges for prostate-specific antigen. Urology. 45(3). 454–458. 14 indexed citations
4.
Abel, P D, et al.. (1994). Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastics and malignant human prostatic epithelium. British Journal of Urology. 74(5). 609–616. 34 indexed citations
5.
Brawn, Peter N., E H Johnson, Donald M. Foster, et al.. (1994). Characteristics of prostatc infarcts and their effect on serum prostate-specific antigen and prostatc acid phosphatase. Urology. 44(1). 71–75. 17 indexed citations
6.
Brawn, Peter N., et al.. (1994). Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms. Cancer. 74(5). 1607–1611. 7 indexed citations
7.
Brawn, Peter N., et al.. (1993). Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer. 71(8). 2569–2573. 125 indexed citations
8.
Brawn, Peter N., et al.. (1992). Effect of Zinc Sulfate and Acetylcysteine on Experimental Gastric Ulcer: In vitro Study. Digestion. 53(1-2). 108–113. 11 indexed citations
9.
Brawn, Peter N.. (1992). Histologic features of metastatic prostate cancer. Human Pathology. 23(3). 267–272. 16 indexed citations
10.
Coffield, K. Scott, V. O. Speights, Peter N. Brawn, & Mark W. Riggs. (1992). Ultrasound Detection of Prostate Cancer in Postmortem Specimens with Histological Correlation. The Journal of Urology. 147(3 Part 2). 822–826. 13 indexed citations
11.
Brawn, Peter N., et al.. (1991). Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer. 68(7). 1592–1599. 63 indexed citations
12.
Brawn, Peter N., et al.. (1990). Stage D1 prostate carcinoma the histologic appearance of nodal metastases and its relationship to survival. Cancer. 65(3). 538–543. 20 indexed citations
13.
Brawn, Peter N. & Charles F. Johnson. (1987). The metastatic potential of prostate carcinomas composed entirely of single malignant glands. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 411(5). 399–402. 3 indexed citations
14.
Brawn, Peter N.. (1987). The characteristics of embryonal carcinoma cells in teratocarcinomas. Cancer. 59(12). 2042–2046. 3 indexed citations
15.
Brawn, Peter N.. (1984). Interpretation of bladder biopsies. Raven Press eBooks. 7 indexed citations
16.
Brawn, Peter N.. (1984). The relationship between non-invasive papillary lesions and invasive bladder carcinoma. Cancer. 54(4). 620–623. 9 indexed citations
17.
Brawn, Peter N.. (1983). Interpretation of prostate biopsies. Raven Press eBooks. 18 indexed citations
18.
Brawn, Peter N.. (1983). The dedifferentiation of prostate carcinoma. Cancer. 52(2). 246–251. 71 indexed citations
19.
Brawn, Peter N.. (1982). Adenosis of the prostate: A dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer. 49(4). 826–833. 70 indexed citations
20.
Dandliker, Walter B., et al.. (1978). Investigation of hormone-receptor interactions by means of fluorescence labeling.. PubMed. 38(11 Pt 2). 4212–24. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D B Siders Breakdown of academic impact, for papers by W A Sakr Breakdown of academic impact, for papers by Sven Wenske Breakdown of academic impact, for papers by S. Melchior Breakdown of academic impact, for papers by H Knönagel Breakdown of academic impact, for papers by Lawrence R. Ragard Breakdown of academic impact, for papers by Paula Kujala Breakdown of academic impact, for papers by Tateki Yoshino Breakdown of academic impact, for papers by Takashi Fukagai Breakdown of academic impact, for papers by S. Pomer
Rankless by CCL
2026